Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting

NCT02725658 is registered in ClinicalTrials.gov with Beckman Laser Institute and Medical Center as lead sponsor.

NCT NCT02725658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting
Lead sponsor
Beckman Laser Institute and Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2015
Completion date
December 31, 2019
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast tumor